Zsa Zsa Weerts

List of publications 273 A List of publications Weerts ZZRM , Essers BAB, Jonkers DMAE, Willems JIA, Janssen DJPA, Witteman BJM, Clemens CHM, Westendorp A, Masclee AAM, Keszthelyi D. A trial-based economic evaluation of peppermint oil for the treatment of Irritable Bowel Syndrome. United European Gastroenterology Journal, 2021, ueg2.12134, Epub ahead of print. Vork L * , Penders J * , Jalanka J, Bojic C, van Kuijk SMJ, Salonen A, de Vos WM, Rajilic Ǧ Stojanovic M, Weerts ZZRM , Masclee AAM, Pozuelo M, Manichanh C, Jonkers DMAE. Does day Ǧ to Ǧ day variability in stool consistency link to the fecal microbiota composition? Frontiers in Cellular and Infection Microbiology, 2021, 20;11:639667. Peiris M, Weerts ZZRM , Aktar R, Masclee AAM, Blackshaw A, Keszthelyi D. A putative anti-inflammatory role for TRPM8 in irritable bowel syndrome – an exploratory study. Neurogastroenterology & Motility, 2021, e14170. Snijkers JTW, van den Oever W, Weerts ZZRM , Vork L, Mujagic Z, Leue C, Hesselink MAM, Kruimel, JW; Muris JWM, Bogie RMM, Masclee AAM, Jonkers DMAE, Keszthelyi D. Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome. Neurogastroenterology & Motility, 2021, e14161. Baumard L, Weerts ZZRM , Masclee AAM, Keszthelyi D, Michael-Titus AT, Peiris M. Effect of Obesity on the Expression of Nutrient Receptors and Satiety Hormones in the Human Colon. Nutrients, 2021, 13(4), 1271. Weerts ZZRM , Heinen KGE, Masclee AAM, Quanjel ABA, Winkens B, Vork L, Rinkens P, Jonkers DMAE, Keszthelyi D. Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study. JMIR Mhealth Uhealth, 2020, 8(11), e19696. Weerts ZZRM , Masclee AAM, Jonkers DMAE, Keszthelyi D. REPLY to GASTRO-D- 19-02037. Gastroenterology, 2020, 159(1), 396-397.